Open Access. Powered by Scholars. Published by Universities.®

Biochemical and Biomolecular Engineering Commons™

Open Access. Powered by Scholars. Published by Universities.®

Honors Theses

Articles 31 - 36 of 36

Full-Text Articles in Biochemical and Biomolecular Engineering

G-Quadruplex Mediated Splicing Of P53 Mrna, Melissa Holy Jan 2016

G-Quadruplex Mediated Splicing Of P53 Mrna, Melissa Holy

Honors Theses

The protein p53 is a master regulator of the cell cycle and its mutation/inactivation is associated with over 50% of cancer cases. Mutations in p53 are associated with worse survival rates, resistance to therapies, and other risk factors in breast cancer specifically. p53 is encoded by the TP53 gene and is expressed as several transcripts. In the G-rich portion of intron 3, secondary DNA structures known as G-quadruplexes are able to form. The stabilization of these G-quadruplexes leads to correct splicing of intron 2, thus making a functional p53 protein. A known quadruplex-stabilizing compound (TMPyP4) was tested to determine its …

Go to article

The Effects Of Genistein, Thymoquinone, Epigallocatechin-3-Gallate,5-Fluorouracil, And Low Level Laser Therapy On Fadu Hypopharyngeal And Laryngeal Carcinoma Cells, Osasu Adah Jan 2016

The Effects Of Genistein, Thymoquinone, Epigallocatechin-3-Gallate,5-Fluorouracil, And Low Level Laser Therapy On Fadu Hypopharyngeal And Laryngeal Carcinoma Cells, Osasu Adah

Honors Theses

Laryngeal and hypopharyngeal carcinoma are two types of head and neck squamous cell carcinomas. The location of the tumor makes it hard to detect without complex tests. Overall, these types of cancer are not common, and there are no simple screening tests for such cancers. Due to this issue, laryngeal and hypopharyngeal carcinoma are usually diagnosed when signs and symptoms occur, such as sore throat, trouble swallowing, and constant coughing. With the use of FaDu, a head and neck cancer cell line of the hypopharyngeal origin, experimentation can be performed in order to initiate possible treatments. The standard treatments for …

Go to article

Targeting G-Quadruplexes Within The Adam-15 Promoter: A Novel Therapeutic Approach For Breast Cancer, Rachel L. Jenkins Jan 2015

Targeting G-Quadruplexes Within The Adam-15 Promoter: A Novel Therapeutic Approach For Breast Cancer, Rachel L. Jenkins

Honors Theses

ADAM-15 is a protein that is up-regulated in many diseases, particularly breast cancer; its over-expression is correlated with more aggressive and invasive phenotypes. The critical core promoter region of ADAM-15 is capable of forming a secondary DNA structure known as a G-quadruplex. The stabilization of this G-quadruplex has the potential to decrease the transcription of the over-expressed ADAM-15 protein. Six hundred forty compounds were screened for their ability to cause a shift in the melting temperature of an ADAM-15 oligonucleotide using FRET melt. Two compounds, NSC 146771 and NSC 260594, produced a significant shift in the melting temperature; further experimentation, …

Go to article

Exploration Of Cannabinoid And Opioid Agents From Plants Used In Traditional Medicine, John Fitzpatrick Jan 2015

Exploration Of Cannabinoid And Opioid Agents From Plants Used In Traditional Medicine, John Fitzpatrick

Honors Theses

Ten plants, with known medicinal uses, were gathered to study for their possible production of secondary metabolites that act as opioid and cannabinoid agents. All plants were subjected to in vitro bioassays testing for their affinity for the opioid and cannabinoid receptors. Banisteriopsis caapi extracts displayed the greatest affinity for both opioid and cannabinoid receptors. B. caapi extracts underwent column fractionation yielding fractions that were subjected to further in vitro studies. We discovered that the ethanolic extract of this plant (foliage) binds to all three opioid receptors (µ, κ and δ) and cannabinoid receptors (CB1 and CB2) with values ranging …

Go to article

Secondary Metabolites Isolated From Perovskia Atriplicifolia And Their In Vitro Binding Affinity For Human Opioid And Cannabinoid Receptors, Ashli Fitzpatrick Jan 2015

Secondary Metabolites Isolated From Perovskia Atriplicifolia And Their In Vitro Binding Affinity For Human Opioid And Cannabinoid Receptors, Ashli Fitzpatrick

Honors Theses

Plants and their natural products have been utilized for thousands of years in the treatment of many human diseases. Because of their structural diversity, natural products are ideal lead compounds for drug development. In this thesis, the natural products of the plant Perovskia atriplicifolia were investigated, specifically their in vitro binding affinity to receptors in opioid and cannabinoid classes. Extracts that demonstrated good selective opioid and cannabinoid receptor binding were subjected to bioassay-guided fractionation. Four active compounds were identified from the crude extract in Perovskia atriplicifolia: 1) 5-hydroxy-3',4',6,7-tetramethoxy flavone, 2) 5,7-dihydroxy-3',4',6,-trimethoxy flavone, 3) 5-hydroxy-4',6,7-trimethoxy flavone, and 4) 5,7-dihydroxy-4',6,-dimethoxy flavone. Each …

Go to article

Design And Synthesis Of Sigma-1 Probe For Positron Emission Tomography (Pet) Imaging, May Ly Jan 2015

Design And Synthesis Of Sigma-1 Probe For Positron Emission Tomography (Pet) Imaging, May Ly

Honors Theses

Sigma-1 receptor radioligands have the potential to detect and monitor various neurological diseases. Because sigma-1 receptors are believed to be associated with numerous psychiatric conditions and neurodegenerative diseases, radioligands for sigma-1 receptors have the potential to serve as novel diagnostic tools and may be useful in assessing treatment effectiveness. A benzothiazolone 18F-labeled sigma-1 receptor ligand, CM304, has demonstrated promise as a specific positron emission tomography radiotracer for visualizing sigma-1 receptors in living subjects. Based on CM304, backup molecules were created to improve the overall drug profile, including half- life and bioavailability.

Go to article

First Prev